Zoetis
ZTS
$0.05 (0.03%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 6 days ago • ZTS
Our Top 10 Picks For Dividend Growth Stocks - September 2023Zacks Investment Research • 10 days ago • ZTS
USNA vs. ZTS: Which Stock Is the Better Value Option?Zacks Investment Research • 16 days ago • ZTS
Why Is Zoetis (ZTS) Down 1.3% Since Last Earnings Report?Business Wire • 16 days ago • ZTS
Zoetis Foundation Announces $2.6 Million in Grants to Advance Opportunities for Veterinarians and Livestock FarmersBusiness Wire • 17 days ago • ZTS
Zoetis to Participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.